Skip to main content
    J

    Jasper Therapeutics Inc (JSPR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.34
    -1.43 (-12.15%)

    Market Cap: $15.18M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Jasper Therapeutics Inc (JSPR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Jasper Therapeutics (JSPR) has a market cap of $15.18M. It kept -1968.63% of revenue as net income over the last 12 months. It holds $135.35M more cash than debt, 891.35% of its market cap.

    Total Valuation

    Market Cap$15.18M
    Latest price (Nov 17, 2026)$10.34

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 96.25% in the quarter ended Sep 30, 2026 and shrank 73.23% a year over 2 years.

    Shares Outstanding1.08M
    Shares Change (YoY)+84.10%
    Shares Change (QoQ)-96.25%
    Share Count Growth (2Y CAGR)-73.23%

    Valuation Ratios

    The price to sales ratio is 1.4x.

    P/S Ratio1.4x
    Forward P/S2.5x

    Price Statistics

    The stock is down 79.48% over 52 weeks and trades 36.87% below its 50-day average.

    Beta (1Y)1.82
    52-Week Change-79.48%
    1-Month Change-27.80%
    3-Month Change-53.84%
    6-Month Change-57.88%
    5-Year Change-99.43%
    Total Return (1Y)-79.48%
    Total Return (3Y CAGR)-62.01%
    Total Return (5Y CAGR)-66.57%
    Return vs SPY (1Y)-92.72%
    Max Drawdown (1Y)-83.37%
    Max Drawdown (3Y)-98.86%
    Sharpe Ratio (1Y)-1.54
    Correlation with SPY (1Y)0.23
    50-Day Average$16.38
    200-Day Average$23.63
    52-Week Range$9.45 to $62.10
    RSI (14 Days)30.4
    Average Volume (20 Days)302.31K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 10.59x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio10.59x
    Quick Ratio10.59x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on Assets (ROA)-106.83%
    ROA (5Y Average)-95.93%
    Asset Turnover0.08x
    Receivables Turnover2.00x

    Scores

    JSPR has an Altman Z-Score of -6.52, in the distress zone below 1.81, and a Piotroski F-Score of 0 of 9, in the weak band of 0 to 2.

    Altman Z-Score-6.52
    Altman Z ZoneDistress
    Piotroski F-Score0 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $8.00M over the last 12 months is up 581.43% from the 12 months before.

    Revenue$8.00M
    Revenue Growth (YoY)+581.43%
    Gross Profit-$283.00K
    Operating Income-$180.17M
    Pretax Income-$157.49M
    Net Income-$157.49M
    Reported EPS (TTM)-$2.22

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$135.35M
    Total Debt$0
    Net Cash$135.35M
    Net Cash Per Share$125.88
    Working Capital$133.36M
    Shareholder Equity-$140.25M
    Total Assets$147.42M
    Total Liabilities$20.89M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$48.83M
    FCF Per Share-$43.99
    Depreciation and Amortization$349.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2252.14%.

    Gross Margin-3.54%
    Operating Margin-2252.14%
    Pretax Margin-1968.63%
    Net Margin-1968.63%

    Growth

    Book Value Per Share Growth (2Y CAGR)-80.48%
    Tangible Book Per Share Growth (2Y CAGR)-80.48%

    Revenue and profit by year

    Dividends and Yields

    JSPR does not pay a dividend.

    Buyback Yield3.06%
    Shareholder Yield3.06%

    Stock Splits

    The last split was a 1-for-30 reverse split on Nov 6, 2026.

    Last Split DateNov 6, 2026
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 5 similar companies, JSPR has the lowest P/S.

    P/S Ratio1.4x vs 6.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+581.43% vs -51.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About JSPR

    What is JSPR's market cap?

    Jasper Therapeutics has a market cap of $15.18M.

    How many shares of JSPR are outstanding?

    Jasper Therapeutics has 1.08M shares outstanding. The count is up 84.10% from a year earlier.

    Does JSPR pay a dividend?

    No. Jasper Therapeutics does not pay a dividend.

    How much debt does JSPR have?

    Jasper Therapeutics has $0 of total debt and $135.35M of cash and equivalents, a net cash position of $135.35M.